Definitive Contract 75N93024C00087
Active Awarded Last action
- Contract number
- 75N93024C00087
- Awardee
-
Ampersand Biosciences LLC UEI HLWQXLFM7JR8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,084,824
Award facts
- Opportunity
-
- PHS202401 Solicitation number
- Contract value 100% obligated
- $1,084,824.00 Current and potential, with all options
- Completion date 84% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- UPPER ST REG, NY 12945, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,084,824 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $1,084,824 firm fixed-price definitive contract to Ampersand Biosciences LLC, a woman-owned small business, for further characterization and validation of monoclonal antibodies to study respiratory disease on September 30, 2024, with completion by March 29, 2027.
Place of performance is Upper St. Regis Region, New York. The originating solicitation calls for development of monoclonal antibodies and immunological research reagents focused on respiratory disease models, supporting non-traditional research subjects including ferrets and mice.
In fiscal year 2024, the contract invoiced $90,000 across 0.2 FTEs and 415 contractor hours, deriving a government-paid rate of $217.84 per hour. Ampersand Biosciences self-performed all reported labor with no subcontractors engaged.
Quick answers
Who was awarded contract 75N93024C00087?
75N93024C00087 was awarded to Ampersand Biosciences LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024C00087 worth?
The government has obligated $1,084,824 on 75N93024C00087.
Was contract 75N93024C00087 competed?
The extent of competition for 75N93024C00087 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award